References
- Martins EP, Fuzzi HT, Kayser C, Alarcon RT, Rocha MG, Chauffaille ML, Increased chromosome damage in systemic sclerosis skin fibroblasts. Scand J Rheumatol 2010;39:398–401.
- van Lieshout AW, Vonk MC, Bredie SJ, Joosten LB, Netea MG, van Riel PL, Enhanced interleukin-10 production by dendritic cells upon stimulation with Toll-like receptor 4 agonists in systemic sclerosis that is possibly implicated in CCL18 secretion. Scand J Rheumatol 2009;38:282–90.
- Lei W, Luo Y, Lei W, Luo Y, Yan K, Zhao S, Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis. Scand J Rheumatol 2009;38:369–74.
- Antonelli A, Ferri C, Fallahi P, Ferrari SM, Giuggioli D, Colaci M, CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis: a longitudinal study. Rheumatology 2008;47:45–9.
- Sato S, Hasegawa M, Takehara K. Serum levels of interleukin-6 and interleukin-10 correlate with total skin thickness score in patients with systemic sclerosis. J Dermatol Sci 2001;27:140–6.
- Hasegawa M, Hamaguchi Y, Yanaba K, Bouaziz JD, Uchida J, Fujimoto M, B-lymphocyte depletion reduces skin fibrosis and autoimmunity in the tight-skin mouse model for systemic sclerosis. Am J Pathol 2006;169:954–66.
- Feghali CA, Bost KL, Boulware DW, Levy LS. Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosis. Autoimmunity 1994;17:309–18.
- Takemura H, Suzuki H, Fujisawa H, Yuhara T, Akama T, Yamane K, Enhanced interleukin 6 production by cultured fibroblasts from patients with systemic sclerosis in response to platelet derived growth factor. J Rheumatol 1998;25:1534–9.
- Antonelli A, Ferri C, Ferrari SM, Colaci M, Giuggioli D, Fallahi P. Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. Br J Dermatol 2010;163:650–1.
- Valentini G, Baroni A, Esposito K, Naclerio C, Buommino E, Farzati A, Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol 2001;21:210–17.
- Kadono T, Kikuchi K, Ihn H, Takehara K, Tamaki K. Increased production of interleukin 6 and interleukin 8 in scleroderma fibroblasts. J Rheumatol 1998;25:296–301.
- Zhou L, Askew D, Wu C, Gilliam AC. Cutaneous gene expression by DNA microarray in murine sclerodermatous graft-versus-host disease, a model for human scleroderma. J Invest Dermatol 2007;127:281–92.
- Schoenborn JR, Wilson CB. Regulation of interferon-gamma during innate and adaptive immune responses. Adv Immunol 2007;96:41–101.
- Scala E, Pallotta S, Frezzolini A, Abeni D, Barbieri C, Sampogna F, Cytokine and chemokine levels in systemic sclerosis: relationship with cutaneous and internal organ involvement. Clin Exp Immunol 2004;138:540–6.
- Raoul JM, Verma M, Tan E, Peterson TC. Cytokines as therapeutic targets for the gastrointestinal manifestations of scleroderma. Can J Gastroenterol 2004;18:22–4.
- Shima Y, Kuwahara Y, Murota H, Kitaba S, Kawai M, Hirano T, The skin of patients with systemic sclerosis softened during the treatment with anti-IL-6 receptor antibody tocilizumab. Rheumatology (Oxford) 2010;49:2408–12.